StructureDefinition-MedicinalProductDefinition-uv-epi

Sourcehl7.fhir.uv.emedicinal-product-info#current:Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v5.0.0)
resourceTypeStructureDefinition
idMedicinalProductDefinition-uv-epi
canonicalhttp://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi
version1.0.0
statusactive
publisherHL7 International - Biomedical Research & Regulation Work Group
nameMedicinalProductDefinitionUvEpi
titleMedicinalProductDefinition (ePI)
date2023-06-14T14:00:01+00:00
descriptionDescription of the packaged authorized medicinal product(s) associated to this ePI document.
jurisdictionsuv
fhirVersion5.0.0
kindresource
abstractfalse
sdTtypeMedicinalProductDefinition
derivationconstraint
basehttp://hl7.org/fhir/StructureDefinition/MedicinalProductDefinition
Usages
Name Flags Card. Type Description & Constraints doco
. . MedicinalProductDefinition MedicinalProductDefinition
. . . identifier 1..
. . . . system 1..
. . . . value 1..
. . . type Regulatory type, e.g. Investigational or Authorized.
. . . domain If this medicine applies to human or veterinary uses.
Binding: Medicinal Product Domain ( example )
. . . version A business identifier relating to a specific version of the product.
. . . status The status within the lifecycle of this product record.
. . . statusDate The date at which this status became applicable.
. . . description General description of the medicinal product referred by the ePI
. . . combinedPharmaceuticalDoseForm Binding: Dose Form ( example )
. . . route Binding: Route Of Administration ( example )
. . . indication Narrative text of the authorized indication(s) for this product.
. . . legalStatusOfSupply The legal status of supply of the medicinal product as classified by the regulator.
. . . additionalMonitoringIndicator Whether the Medicinal Product is subject to additional monitoring for regulatory reasons.
. . . specialMeasures Whether the Medicinal Product is subject to special measures for regulatory reasons.
. . . pediatricUseIndicator If authorised for pediatric use
. . . classification Allows the product to be classified by various systems (e.g. ATC)
. . . marketingStatus
. . . . country Binding: ISO Country two letter code ( preferred )
. . . . status Status of the marketing of the medicinal product.
. . . . dateRange The date when the Medicinal Product is placed on the market by the Marketing Authorization Holder
. . . packagedMedicinalProduct Package type for the product.
. . . contact
. . . . type Allows the contact to be classified, for example QPPV, Pharmacovigilance Enquiry Information.
. . . . contact A specific contact, person (in a role), or an organization for this product
. . . name
. . . . productName The full product name.
. . . . type Type of product name, such as rINN, Proprietary, Non-Proprietary
. . . . part
. . . . . part A fragment of a product name.
. . . . . type Type for this part of the name (e.g. strength part)
. . . . usage
. . . . . country Country where this name applies
. . . . . jurisdiction Jurisdiction where this name applies
. . . . . language Language for this name

doco Documentation for this format

Produced 08 Sep 2023